Furthermore, RBM6 is downregulated in laryngeal carcinoma tissues and cell lines, whose upregulation can inhibit cell proliferation and promote apoptosis by activating the ERK pathway [21]. This evidence concerns the gene RBM6 and laryngeal carcinoma.